CREON(R) (pancrelipase) Delayed-Release Capsules Improves Digestive Outcomes In Adults With Chronic Pa... ( MARIETTA Ga. Oct. 26 /- Solvay Pharma...)

CREON(R) (pancrelipase) Delayed-Release Capsules Improves Digestive Outcomes In Adults With Chronic Pancreatitis

Date:10/26/2009

MARIETTA, Ga., Oct. 26 /PRNewswire/ -- Solvay Pharmaceuticals, Inc. announced today that new data demonstrate that CREON®( )(pancrelipase) Delayed-Release Capsules significantly improves a key measure of fat absorption in adults with exocrine pancreatic insufficiency (EPI) due to chronic pancreatitis (CP) or pancreatic surgery. EPI is a condition resulting from a deficiency in the production and/or secretion of pancreatic enzymes that are necessary to digest nutrients in food and, if untreated, can lead to diarrhea, weight loss and ultimately malnutrition.

Findings from this Phase III study, which have been submitted to the FDA, were presented at the American College of Gastroenterology Annual Scientific Meeting in San Diego, California, on Sunday, October 25th, by Dr. David C. Whitcomb, in a poster titled "Efficacy and safety of pancrelipase delayed-release capsules (CREON®) in patients with pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery," poster number P101. Among FDA-approved pancreatic enzyme replacement therapies (PERTs), this study provides important new data to evaluate PERT dosing specifically in patients with EPI due to CP or pancreatic surgery.

"The maldigestion associated with EPI due to chronic pancreatitis and pancreatic surgeries can result in malnutrition as well as debilitating pain and GI symptoms that negatively impact quality of life for these patients," said David C. Whitcomb, M.D., Ph.D., University of Pittsburgh Medical Center. "These data support the use of PERT to improve the absorption of fat in patients receiving diets of at least 100 g of fat per day, which serves as an important demonstration to clinicians that EPI can be effectively treated without restricting patients' diets to be very low in fat."

According to the study results, adults with CP or who have undergone pancreatic surgery, who took CREON®, had an improved coefficient of fat absorption (
'/>"/>

SOURCE Solvay Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6
Related medicine technology :

1. Results Published In Journal of Cystic Fibrosis Confirm CREON(R) (pancrelipase) Delayed-Release Capsules Improves Fat Absorption in Patients With Cystic Fibrosis
2. CREON(R) (pancrelipase) Delayed-Release Capsules Improves Absorption of Fat in Young Children With Cystic Fibrosis
3. Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets
4. Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA
5. GSK Receives Approval for HYCAMTIN(R) (topotecan) Capsules for the Treatment of Relapsed Small Cell Lung Cancer
6. Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting
7. Roxane Laboratories, Inc. Updated Launch of Calcium Acetate Capsules, 667mg
8. Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
9. Experimental Drug Ketasyn(TM) Improves Memory in Age-Associated Memory Impairment Study
10. First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
11. New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer

Post Your Comments:

(Date:11/23/2009)...3/PRNewswire/--Reportlinker.comannouncesthatanewma... TheFutureoftheDiagnosticImagingMarketto2015 ,...re-of-the-Diagnostic-Imaging-Market-to-2015.html#u...paign=prnewswire ,, Description ,, The...mmary ,, GlobalMarketsDirect,s"TheFutureoftheD...

(Date:11/23/2009)...3/PRNewswire/--Reportlinker.comannouncesthatanewma... U.S.MarketforPACSandEMR ,, http://www.repo...tml#utm_source=prnewswire&utm_medium=pr&ut...rPACSwasvaluedatalmost$1.3billion,representinganin...pitals(500+beds),mediumhospitals(201-499beds),comm...

(Date:11/23/2009)...ON,Nov.23/PRNewswire-FirstCall/--AMICAS,Inc.(Nasda...lutions,todayannouncedthatitwillhighlightitsenterp...lSocietyofNorthAmerica(RSNA)annualmeetingfromNovem...hHallinbooth#7124. ,, (Logo: http://www.newscom...enthenationalconversationabouthealthcarereform,the...

[0] Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 [0] Reportlinker Adds U.S. Market for PACS and EMR [0] AMICAS' Enterprise Imaging Solutions Highlighted at RSNA 2009

...d seamless completion of clinical trial enrollment...mized patients, market research, an effective recr... real time metrics. , , MediciGlobal,s President...n clinical trial sites are engaged and motivated t...emistry with the study sponsor -- a major Pharma c...

...uticals, a privately-held biopharmaceutical compan...t in the Company,s second pivotal Phase 3 clinical...her with the previously completed first pivotal Ph... enrolled its planned pivotal Phase 3 studies for ... therapy currently in development for the treatmen...

Other Medicine Technology:Major Restless Legs Study Completes Enrollment With Support From MediciGlobal 2 QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy 2 QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy 3

Major Restless Legs Study Completes Enrollment With Support From MediciGlobal QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy

(Date:11/23/2009)...wswire-USNewswire/--TheAmericanSocietyofHematology...ducation,andmediacompany,arelaunching"ExploretheMy...parkinterestinthefieldsofscienceandmedicine,inaddi...sinhematology. ,, "Manyhematologistsmayremember...nt,whichmadelearningaboutbloodreallyfun,"statedNan...

(Date:11/23/2009)...hildren who don,t access health care from the same...antly more likely to have unmet health care needs ...ublished in the journal Pediatrics . , Studies...and delivery of quality health care for children, ...y debates about health insurance reform, much of t...

(Date:11/23/2009)...p by 63 percent with moderate-to-high intensity wo...ws) -- Moderate-to-high intensity exercise such as...e risk in older men but not in women, researchers ...nd women, average age 69, in Manhattan who were fo...re were 238 strokes among the participants. At the...

(Date:11/23/2009)...an to head the agency, said lives could be at risk... The fallout from last week,s controversial recomm...mogram testing for breast cancer continues, with a...alth advising women to ignore the guidelines. ,...unequivocally this will increase the number of wom...

(Date:11/23/2009)...3/PRNewswire/--Hazelden,theinternationallyrenowned...eleadershipteamforitsnewrecoverycenterinNaples,Flo...openinlateMarch2010,andwillinitiallyprovideaddicti...familyandoutpatientservices. ,, MichaelDemask,P...ityinNaples,withBrendaIliff,M.A.,L.A.D.C.,asclinic...

Breaking Medicine News(10 mins):Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 2 Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 3 Health News:Children who lack continuity with a regular health care provider miss needed services 2 Health News:Children who lack continuity with a regular health care provider miss needed services 3 Health News:Vigorous Exercise Cuts Stroke Risk for Men, Not Women 2 Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 2 Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 3 Health News:Hazelden Names Leadership Team for New Recovery Center in Naples, Florida 2

[0] New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology [0] Children who lack continuity with a regular health care provider miss needed services [1] Vigorous Exercise Cuts Stroke Risk for Men, Not Women [1] Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says [1] Hazelden Names Leadership Team for New Recovery Center in Naples, Florida

...n for Babies, NEW YORK, April 17 Thousands of Ma... MVP Eli Manning on Sunday, April 27,when March fo... from,Lincoln Center at 65th St. in Manhattan. Man...CBS 2 News Co-Anchor,Maurice DuBois, and CBS 2 Rep...

...FirstCall/ -- Lotus,Pharmaceuticals, Inc. (OTC Bul...armaceutical company in the People,s Republic of C...r the fourth quarter and,fiscal year ended Decembe...ofit reached $8.3 million, up 234% from the fourth...

...g-Lasting Benefits, DALLAS, April 17 Affiliated ...ced that it has successfully,completed Phase I of ...ation System (IHIS), a program to attain the highe...that connects laboratory, radiology, and,image arc...

...on Capitol Hill to Ask U.S. to,Meet Obligations to...he White Ribbon,Alliance for Safe Motherhood today...n,s health to Capitol Hill. Citing recent reports ...frica, they,were joined by Congressional leaders w...

...nsumer,Watchdog today joined L.A. City Attorney Ro...leging that health insurer Blue Cross engaged in u...he health insurance of patients,after they got sic...undreds of thousands of dollars in medical debt wh...

...staurant,Association issued the following statemen...rt decision regarding a New York City Board of Hea...ation should be provided in,some of the city,s res...y,help consumers receive nutrition information tha...

Eli Manning Leads March for Babies in Manhattan Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results ACS Systems Improving Delivery of Healthcare in Malta White Ribbon Alliance Calls for Investments to Save Women's Lives Lost in Pregnancy and Childbirth Consumer Watchdog Applauds L.A. City Attorney's Efforts to Reinstate Cancelled Blue Cross Patients; Urges State HMO Regulator to Do Same National Restaurant Association Expresses Disappointment About Court Ruling on Menu Labeling in New York City

MiniCycler thermal cycler

Dual-bay Dyad thermal cycler chassis

...h 24-well x 0.2ml sub-ambient block and automatic ...tor) Heating rates: up to 3C/second; Accurate bloc...-99C; Excellent uniformity: better than 0.5C withi...ramming: directory program storage of up to 60 pro...

...r unit is an inexpensive personal or mini thermal ... Lightweight, with a small footprint, it can be ea...ng the researcher's desk. , The Gene Cycler t...o not have access to a large laboratory thermal cy...

Medicine Products:

MiniCycler thermal cycler Dual-bay Dyad thermal cycler chassis PCR Sprint Thermal Cycler Gene Cycler Thermal Cycler

CREON(R) (pancrelipase) Delayed-Release Capsules Improves Digestive Outcomes In Adults With Chronic Pa...( MARIETTA Ga. Oct. 26 /- Solvay Pharma...),Health